| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84466 |
cas:2055041-40-0,Azido-PEG1-Val-Cit-PAB-OH,叠氮-一聚乙二醇-VAL-CIT-PAB-羟基 |
134 |
kx |
2024-12-19 |
| 84467 |
MB-VC-MGBA CAS号:932744-62-2 |
220 |
WYQ |
2024-12-19 |
| 84468 |
Anti-GPNMB-VC-MMAE-ADC抗体偶联药物 |
173 |
zyl |
2024-12-19 |
| 84469 |
MA-PEG8-VA-PAB-SG3199,硫醇反应SET™毒素 |
224 |
WYQ |
2024-12-19 |
| 84470 |
cas:1662687-83-3 , Mal-PEG2-Val-Cit-PABA,马来酰亚胺-二聚乙二醇-VAL-CIT-PABA |
148 |
kx |
2024-12-19 |
| 84471 |
Boc-Val-Ala-PAB cas:1884577-99-4 |
208 |
zyl |
2024-12-19 |
| 84472 |
perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate |
160 |
wyh |
2024-12-19 |
| 84473 |
MA-PEG4-VA-PBD(CAS号:2259318-50-6) |
181 |
WYQ |
2024-12-19 |
| 84474 |
SPDP-Val-Cit-PAB-PNP-ADC抗体偶联药物 |
229 |
zyl |
2024-12-19 |
| 84475 |
cas:1438853-35-0,Mal-PEG3-Val-Cit-PAB-PNP,马来酰亚胺-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
158 |
kx |
2024-12-19 |
| 84476 |
Mc-vc-PABC-SP 141,一种用于抗体药物偶联物(ADC)合成的linker或连接臂 |
235 |
WYQ |
2024-12-19 |
| 84477 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
233 |
wyh |
2024-12-19 |
| 84478 |
cas:2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH,马来酰亚胺-一聚乙二醇-VAL-CIT-PAB-羟基 |
236 |
kx |
2024-12-19 |
| 84479 |
perfluorophenyl 15-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3,6,9-trioxa-12-azapentadecan-1-oate |
156 |
wyh |
2024-12-19 |
| 84480 |
MC-Val-Cit-PAB-PNP cas:159857-81-5 |
220 |
zyl |
2024-12-19 |
| 84481 |
NAMPT-linker(CAS号:2241019-57-6) |
164 |
WYQ |
2024-12-19 |
| 84482 |
cas:103848-61-9,6-Maleimidocaproic acid sulfo-NHS |
178 |
wyh |
2024-12-19 |
| 84483 |
cas:159857-80-4 ,MC-Val-Cit-PAB-OH, ADC(抗体偶联药物 ) |
158 |
kx |
2024-12-19 |
| 84484 |
Boc-Val-Cit cas:870487-08-4 |
208 |
zyl |
2024-12-19 |
| 84485 |
cas:663598-66-1,1-((4-((5-Nitropyridin-2-yl)disulfanyl)pentanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
170 |
wyh |
2024-12-19 |
| 84486 |
cas:870487-10-8,Boc-Val-Cit-PAB-PNP,BOC-VAL-CIT-PAB-PNP 酯 |
155 |
kx |
2024-12-19 |
| 84487 |
cas:2353409-69-3 Mal-PEG8-Val-Cit-PAB-MMAE |
217 |
zyl |
2024-12-19 |
| 84488 |
cas:108852-90-0 Nemorubicin 奈莫柔比星 |
184 |
zyl |
2024-12-19 |
| 84489 |
cas:159858-22-7 , Fmoc-Val-Cit-PAB-OH,ADC(抗体偶联药物) |
162 |
kx |
2024-12-19 |
| 84490 |
cas:1626359-59-8 磺基-SPDB-DM4 |
131 |
zyl |
2024-12-19 |
| 84491 |
cas:870487-09-5,Boc-Val-Cit-PAB, ADC试剂 |
132 |
kx |
2024-12-19 |
| 84492 |
NH2-Glu-Gly-Cit-PAB-OH, ADC试剂 |
214 |
kx |
2024-12-19 |
| 84493 |
sulfo-SPDB-DGN462,用于提高化合物的水溶性和稳定性 |
256 |
WYQ |
2024-12-19 |
| 84494 |
Fmoc-Gly-Gly-Phe-Gly-OH, ADC试剂 |
196 |
kx |
2024-12-19 |
| 84495 |
1342211-31-7,MC-Val-Ala-OH,马来酰亚胺基己酰-L-缬氨酰-L-丙氨酸,ADC连接子多肽 |
221 |
kx |
2024-12-19 |
| 84496 |
MA-PEG4-VC-PAB-DMAE-PNU159682(CAS号:2259318-52-8) |
163 |
WYQ |
2024-12-19 |
| 84497 |
MC-vc-PAB-C6-a-amanitin,一种抗体药物偶联物(ADC) |
193 |
WYQ |
2024-12-19 |
| 84498 |
cas:690632-55-4,N-Succinimidyloxycarbonylpropyl Methanethiosulfonate |
120 |
wyh |
2024-12-19 |
| 84499 |
VC-MMAF(CAS号:863971-17-9) |
164 |
WYQ |
2024-12-19 |
| 84500 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin-ADC抗体偶联药物 |
130 |
zyl |
2024-12-19 |
| 84501 |
2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 |
147 |
kx |
2024-12-19 |
| 84502 |
cas:1834516-06-1 Fmoc-Ala-Ala-Asn-PABC-PNP |
154 |
zyl |
2024-12-19 |
| 84503 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
179 |
wyh |
2024-12-19 |
| 84504 |
MC -Val-Cit, ADC试剂 |
222 |
kx |
2024-12-19 |
| 84505 |
cas:141534-26-1,2-(4-formylbenzamido)ethyl nitrate |
215 |
wyh |
2024-12-19 |
| 84506 |
cas:159857-81-5 Mc-Val-Cit-PABC-PNP |
163 |
zyl |
2024-12-19 |
| 84507 |
MC-PEG4-va-PAB-Exatecan, ADC试剂 |
343 |
kx |
2024-12-19 |
| 84508 |
cas:2101206-44-2 PY-DS-DMBUT-OPFP |
189 |
zyl |
2024-12-19 |
| 84509 |
Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate |
134 |
wyh |
2024-12-19 |
| 84510 |
SMCC-DM4(CAS号:1228105-52-9) |
153 |
WYQ |
2024-12-19 |